BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 20357365)

  • 1. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
    Sarruf DA; Thaler JP; Morton GJ; German J; Fischer JD; Ogimoto K; Schwartz MW
    Diabetes; 2010 Jul; 59(7):1817-24. PubMed ID: 20357365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
    Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
    Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 decreases food intake and body weight in obese Göttingen minipigs.
    Christoffersen B; Straarup EM; Lykkegaard K; Fels JJ; Sass-Ørum K; Zhang X; Raun K; Andersen B
    Diabetes Obes Metab; 2019 Mar; 21(3):592-600. PubMed ID: 30328263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice.
    Camacho RC; Zafian PT; Achanfuo-Yeboah J; Manibusan A; Berger JP
    Eur J Pharmacol; 2013 Sep; 715(1-3):41-5. PubMed ID: 23831019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
    Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
    Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
    Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
    Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of metabolic health by decreased consumption of branched-chain amino acids.
    Cummings NE; Williams EM; Kasza I; Konon EN; Schaid MD; Schmidt BA; Poudel C; Sherman DS; Yu D; Arriola Apelo SI; Cottrell SE; Geiger G; Barnes ME; Wisinski JA; Fenske RJ; Matkowskyj KA; Kimple ME; Alexander CM; Merrins MJ; Lamming DW
    J Physiol; 2018 Feb; 596(4):623-645. PubMed ID: 29266268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates.
    Thompson WC; Zhou Y; Talukdar S; Musante CJ
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):411-25. PubMed ID: 27405817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
    Makarova E; Kazantseva A; Dubinina A; Jakovleva T; Balybina N; Baranov K; Bazhan N
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
    Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
    Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
    Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
    J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.
    Nogueiras R; Veyrat-Durebex C; Suchanek PM; Klein M; Tschöp J; Caldwell C; Woods SC; Wittmann G; Watanabe M; Liposits Z; Fekete C; Reizes O; Rohner-Jeanrenaud F; Tschöp MH
    Diabetes; 2008 Nov; 57(11):2977-91. PubMed ID: 18716045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Satjaritanun P; Wang X; Liang G; Li X; Jiang C; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Horm Behav; 2016 Sep; 85():86-95. PubMed ID: 27566237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M; Aust L; Frenz U; Noack R
    Ann Nutr Metab; 1996; 40(1):10-23. PubMed ID: 8722302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
    Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
    Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals.
    Slusher AL; Whitehurst M; Zoeller RF; Mock JT; Maharaj M; Huang CJ
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):839-845. PubMed ID: 26141939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.